2Lopez AD,Murray CC.The global burden of disease,1990-2020.Nat Med,1998,4 (11):1241-1243.
3Gorecka D,Sliwinski P,Palasiewicz G,et al.Effects of almiteine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia:a multicentre,randomised,doubleblind,placebo-controlled study.Respiration,2003,70 (3):275-283.
5Simonneau G,Hernandez LA.Cardiopulmonary effects of a single oral dose of Almitrine at rest and on exercise in patients with hypoxic airway obstruction.Chest,1986,89 (7):174.
1Depresseix JC, Franck G, van Cauwenderge H. Metabolic and circulatory evaluation of acute cerebral ischemic accident in man by positron emission tomography. Prresse Med, 1987,16 : 1145-1150.
3Zugck C,Krüger C,Dürr S.Is the6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy[J].Eur Heart J,2000,21(7):540-549.
4Gosker H R,Engelen M P,Van Mameren H,et al.Muscle fiber type IIX atropHy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease[J].Am J Clin Nutr,2002,76(1):113-119.
5Winkelmann B R,Kullmer T H,Kneissl D G,et al.Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease[J].Chest,1994,105(5):1383-1391.
